Used as an intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) requiring chiral pyrrolidine scaffolds. Its protected amine group allows for selective reactions in multi-step organic syntheses. Commonly employed in the production of neurology and psychiatric disorder medications due to the pyrrolidine ring’s presence in bioactive molecules. Also utilized in research settings for designing enzyme inhibitors and receptor ligands.